264 related articles for article (PubMed ID: 393789)
1. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
Müller R; Schröer R
J Med; 1979; 10(5):347-64. PubMed ID: 393790
[TBL] [Abstract][Full Text] [Related]
3. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
Müller R; Lebrach F
Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
[TBL] [Abstract][Full Text] [Related]
4. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
Müller R
J Med; 1981; 12(4):209-35. PubMed ID: 7031157
[TBL] [Abstract][Full Text] [Related]
5. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Ehrly AM
J Med; 1979; 10(5):331-8. PubMed ID: 294470
[No Abstract] [Full Text] [Related]
6. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
7. The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review.
Schönharting M; Musikić P; Müller R
Pharmatherapeutica; 1988; 5(3):159-69. PubMed ID: 3283776
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Strano A; Davì G; Novo S; Avellone G; Pinto A
Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
[No Abstract] [Full Text] [Related]
9. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
Eninia GI; Egere DA; Robule VKh; Maĭore IKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):50-2. PubMed ID: 3953193
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
12. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
Aviado DM; Dettelbach HR
Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
[TBL] [Abstract][Full Text] [Related]
15. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Ehrly AM
Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
[TBL] [Abstract][Full Text] [Related]
17. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1979; 10(5):339-45. PubMed ID: 119023
[No Abstract] [Full Text] [Related]
18. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Benignetti G; Fabbri F; Benvenuti C
Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
[No Abstract] [Full Text] [Related]
19. Pentoxifylline and cerebrovascular diseases.
Marcel GA; George C
Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
[TBL] [Abstract][Full Text] [Related]
20. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
